| HOME >> BIOLOGY >> TECHNOLOGY |
AUSTIN, Texas and TORONTO, Oct. 3 /PRNewswire/ -- Two leading companies in their respective industries are joining forces to integrate vibration therapy into the stem cell harvesting process.
SpineSmith Partners LP, an orthopedic biotech company based in Austin, Texas, has signed an exclusive national and global distribution agreement with WAVE(R) Manufacturing Inc., of Toronto, Ontario. The partnership between the two companies grants SpineSmith the exclusive rights to sell WAVE's pre-surgical vibration conditioning technology -- effectively introducing the approach to the orthopedic and neurological marketplace.
The WAVE system, which stands for Whole-body Advanced Vibration Exercise, allows patients with medical conditions such as obesity, diabetes, and arthritis to improve their fitness at a cellular level before spinal surgery.
Recent scientific research indicates the type of vibration process WAVE technology produces, which is similar to vigorous exercise, can improve circulation, reduce pain, and increase flexibility, with minimal stress to joints -- and in a fraction of the time of conventional therapies. Increasing circulation helps prepare the surgical site by stimulating the body's natural healing response and also promotes revascularization and recovery after surgery. WAVE technology can also stimulate and produce growth factors to recruit regenerative cells that play an important role in healing and recovery.
"This is all about creating the best healing environment for the patient, and WAVE technology makes that possible," said Kevin Dunworth, SpineSmith founder. "The most recent scientific literature indicates an up regulation of stem cells, hormones, and growth factors when a patient undergoes vigorous exercise. We believe the up regulation of stem cells will stimulate better surgical outcomes."
"SpineSmith is about regenerative medicine, and this is just the
beginning," Dunworth said. "We're all about keeping
'/>"/>
| SOURCE SpineSmith Partners, LP Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
2. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
3. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
4. Healionics Corporation Announces Partnership to Develop and Distribute STARcuff(TM)
5. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
6. VIA Pharmaceuticals Lead Compound, VIA-2291, Chosen as a Top Ten Most Licensable Cardiovascular Program for Windhover Informations Therapeutic Area Partnerships Conference
7. Salugen Expands U.S. Distribution and Announces a Partnership with DNA Dimensions to Bring DNA Customized Nutritional Solutions to Metro Detroit Area
8. Elbit Medical Imaging Ltd. Announces that Plaza Centers Has Entered into a Joint Venture Partnership to Develop Residential and Office Projects in Romania
9. NPS Pharmaceuticals to Report Third Quarter 2007 Financial Results and Nycomed Decision on GATTEX(TM) Partnership on November 1, 2007
10. LifeNet Health and IMS Announce Partnership
11. Carl Marks Seeds New Healthcare Fund Through Strategic Partnership With BlueStar Capital Management
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |